National Comprehensive Cancer Network



About NCCN

Chronic Myelogenous Leukemia Panel - Disclosures as of 11/19/2012

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Attendance

Camille N. Abboud, MD

None

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Celgene Corporation;
Incyte

None

None

None

Mojtaba Akhtari, MD

None

None

None

None

None

Jessica Altman, MD

None

Celgene Corporation;
Astellas;
Teva

None

None

None

Ellin Berman, MD

None

None

None

None

None

Adam D. Cohen, MD

None

Bristol-Myers Squibb Company;
Celgene Corporation;
Celgene Corporation

None

None

None

Daniel J. DeAngelo, MD, PhD

None

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Sigma-Tau Pharmaceuticals, Inc.

None

None

None

Steven Devine, MD

Genzyme Corporation

Novartis Pharmaceuticals Corporation

None

None

None

Amir T. Fathi, MD

None

Genzyme Corporation;
Concert Pharma;
Seattle Genetics;
Teva Pharmaceuticals

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Jason Gotlib, MD, MS

None

Novartis Pharmaceuticals Corporation

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Madan Jagasia, MD

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Joseph O. Moore, MD

ARIAD Pharmaceuticals, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

Amgen Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

None

Susan O'Brien, MD

None

Hana Biosciences, Inc.

None

None

None

Arnel Pallera, MD

None

None

None

None

None

Javier Pinilla-Ibarz, MD, PhD

None

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

None

None

None

Jerald P. Radich, MD

Novartis Pharmaceuticals Corporation

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

None

Vishnu VB. Reddy, MD

None

None

None

None

None

Neil P. Shah, MD, PhD

None

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company

None

None

None

Paul J. Shami, MD

None

Genzyme Corporation;
Novartis Pharmaceuticals Corporation;
Novartis Pharmaceuticals Corporation

None

None

None

B. Douglas Smith, MD

None

Novartis Pharmaceuticals Corporation

None

None

None

David S. Snyder, MD

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

Bristol-Myers Squibb Company;
Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

None

None

None

Hema Sundar, PhD

None

None

None

None

Cephalon, Inc.

Meir Wetzler, MD

None

Amgen Inc.;
Teva

None

None

None